Clinical Trial

Institutional Registry of Haemorrhagic Hereditary Telangiectasia

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to create an institutional and population-based registry of Haemorrhagic Hereditary Telangiectasia with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival. This study will also describe the occurrence of Haemorrhagic Hereditary Telangiectasia in the population of HIBA in the Central Hospital, as well as the characteristics of clinical presentation and evolution.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2013-01-03; most recent amendment 2025-05-19.
Trial Details
NCT Number NCT01761981
Lead Sponsor Hospital Italiano de Buenos Aires
Conditions Haemorrhagic Hereditary Telangiectasia
Enrollment 590 participants
Start Date 2010-01-01
Primary Completion 2025-05-19 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-30